623.95MMarket Cap-5663P/E (TTM)
12.240High11.510Low432.81KVolume11.650Open11.430Pre Close5.14MTurnover1.18%Turnover RatioLossP/E (Static)52.97MShares17.58052wk High2.69P/B434.09MFloat Cap3.77652wk Low--Dividend TTM36.85MShs Float71.580Historical High--Div YieldTTM6.39%Amplitude3.350Historical Low11.867Avg Price1Lot Size
Stoke Therapeutics Stock Forum
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet